Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2007;38:817-826
doi: 10.1161/01.STR.0000247888.25985.62
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bliss, T.
Right arrow Articles by Steinberg, G. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bliss, T.
Right arrow Articles by Steinberg, G. K.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Animal models of human disease

(Stroke. 2007;38:817.)
© 2007 American Heart Association, Inc.


Stem Cells and Stroke Recovery: Introduction

Cell Transplantation Therapy for Stroke

Tonya Bliss, PhD; Raphael Guzman, MD; Marcel Daadi, PhD Gary K. Steinberg, MD, PhD

From the Department of Neurosurgery (T.B., R.G., M.D., G.K.S.) and Stanford Stroke Center (G.K.S.), Stanford University, Stanford, Calif.

Correspondence to Dr G.K. Steinberg, Department of Neurosurgery, R281, Stanford University School of Medicine, 300 Pasteur Dr, Stanford, CA 94305. E-mail cerebral{at}stanford.edu

Abstract

No treatment currently exists to restore lost neurological function after stroke. A growing number of studies highlight the potential of stem cell transplantation as a novel therapeutic approach for stroke. In this review we summarize these studies, discuss potential mechanisms of action of the transplanted cells, and emphasize the need to determine parameters that are critical for transplantation success.


Key Words: clinical trials • neural stem/progenitor cells • stroke • transplantation parameters




This article has been cited by other articles:


Home page
Neurorehabil Neural RepairHome page
P. Stroemer, S. Patel, A. Hope, C. Oliveira, K. Pollock, and J. Sinden
The Neural Stem Cell Line CTX0E03 Promotes Behavioral Recovery and Endogenous Neurogenesis After Experimental Stroke in a Dose-Dependent Fashion
Neurorehabil Neural Repair, November 1, 2009; 23(9): 895 - 909.
[Abstract] [PDF]


Home page
BrainHome page
M. Bacigaluppi, S. Pluchino, L. P. Jametti, E. Kilic, U. Kilic, G. Salani, E. Brambilla, M. J. West, G. Comi, G. Martino, et al.
Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms
Brain, August 1, 2009; 132(8): 2239 - 2251.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
W. Cai, R. Guzman, A. R. Hsu, H. Wang, K. Chen, G. Sun, A. Gera, R. Choi, T. Bliss, L. He, et al.
Positron Emission Tomography Imaging of Poststroke Angiogenesis
Stroke, January 1, 2009; 40(1): 270 - 277.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. P.W. Rouhl, R. J. van Oostenbrugge, J. Damoiseaux, J.-W. C. Tervaert, and J. Lodder
Endothelial Progenitor Cell Research in Stroke: A Potential Shift in Pathophysiological and Therapeutical Concepts
Stroke, July 1, 2008; 39(7): 2158 - 2165.
[Abstract] [Full Text] [PDF]